Day: May 15, 2024

Jet.AI Reports First Quarter 2024 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Increase in total revenues of 105% year-over-year 17% point increase in net margin, adjusted for stock option expense Cash and cash equivalents of $2.1 million as of April 1st, unchanged from December 31st, 2023 LAS VEGAS, May 15, 2024 (GLOBE NEWSWIRE) — Jet.AI Inc. (the “Company”) (Nasdaq: JTAI), an innovative private aviation and artificial intelligence (“AI”) company, today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 and Recent Operational Highlights Released the National Jet Card Program using third party aircraft Announced partnership with FL3XX to integrate its DynoFlight carbon removal platform making it an easy option for thousands of FL3XX customers Launched Reroute AI, a web-based software tool designed to transform the way empty flight legs are utilized As previously...

Continue reading

Natural Gas Services Group, Inc. Reports First Quarter 2024 Financial and Operating Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Midland, Texas, May 15, 2024 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (“NGS” or the “Company”) (NYSE:NGS), a leading provider of natural gas compression equipment, technology and services to the energy industry, today announced financial results for the three months ended March 31, 2024. First Quarter 2024 Highlights Rental revenue of $33.7 million, an increase of 48% when compared to the first quarter of 2023 and 7% when compared to the fourth quarter of 2023. Net income of $5.1 million, or $0.41 per basic share, as compared to a net income of $0.4 million, or $0.03 per basic share in the first quarter of 2023 and net income of $1.7 million, or $0.14 per basic share in the fourth quarter of 2023. Adjusted EBITDA of $16.9 million, compared to $7.8 million in the first quarter of 2023 and $16.3 million in the fourth...

Continue reading

CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Reported Full Year 2023 total revenues of 2% growth at €48.5 million Secured approximately USD 20 million – strengthening cash position and expanding relationship with Lifera, a biopharma company owned by the PIF Positioned for strong performance in 2024, driven by new and existing Pharma business and solid Diagnostic growth in line with industry standards; guidance of FY2024 total revenue growth between 10-15% Ongoing strategic alternatives process focused on sustainable long-term value creation for the benefit of its stakeholders CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 15, 2024 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG) (“we” or the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced financial results for the fiscal year ended December...

Continue reading

Zeo Energy Corp. Reports First Quarter 2024 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

First Quarter 2024 Highlighted by Total Revenue Growth of 4% to $19.5 Million NEW PORT RICHEY, Fla., May 15, 2024 (GLOBE NEWSWIRE) — Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo”, “Zeo Energy”, or the “Company”), a leading Florida-based provider of residential solar and energy efficiency solutions, today reported financial results for the first quarter ended March 31, 2024. Recent Financial and Operational Highlights Total revenue for the first quarter 2024 increased 4% to $19.5 million year-over-year Gross profit for the first quarter 2024 decreased 47% to $1.8 million year-over-year Adjusted EBITDA for the first quarter 2024 resulted in a loss of $1.2 million Completed merger with ESGEN Acquisition Corp. on March 13, 2024 (the “Business Combination”), resulting in shares and warrants trading on the Nasdaq Capital Market under the...

Continue reading

Mawson Infrastructure Group Inc. Reports Q1 2024 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Q1 2024 Total Revenue increased 145% Y/Y and 34% Q/Q Q1 Co-Location Business Revenue increased 90% Y/Y and 83% Q/Q Q1 Energy Management Business Revenue increased 461% Y/Y and 2% Q/Q Company optimized and reduced Q1 SG&A expenses by 30% Y/Y and 19% Q/Q MIDLAND, Pa., May 15, 2024 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson”, “the Company”), a digital infrastructure company, today announced its unaudited financial and operational results for the first quarter of fiscal year 2024 ended March 31, 2024. “We are delighted with the overall revenue increase during the first quarter of 2024 —145% year-on-year growth and 34% quarter-on-quarter growth, in addition to our progressing the Company’s strategic, operational, and technological plans in Q1, 2024,” said Rahul Mewawalla, CEO and President of Mawson....

Continue reading

Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Announced positive data from Cohort 1 of the Phase 1b clinical trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) patients with positive trends observed in seven of the eight biomarkers evaluated Topline results from Cohort 2 evaluating high-dose LTI-03 (5 mg BID) expected in the third quarter of 2024 AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) — Aileron Therapeutics, Inc. (“Aileron” or the “Company”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today reported financial results for the first quarter ended March 31, 2024, and provided a business update. “In the first quarter, we made steady progress against our key priorities of advancing LTI-03 and generating data from Cohort 1 in IPF,”...

Continue reading

Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action, today reported financial results and business updates for the first quarter of 2024. Recent Company Highlights MTEM presented clinical data at the 2024 AACR Annual Meeting that demonstrated MT-6402’s tolerable safety and promising efficacy profile in relapsed/refractory HNSCC patients. As monotherapy in 7 evaluable HNSCC patients (all heavily pretreated and checkpoint experienced), 2 confirmed PRs (ongoing at 10 and 20 months, respectively) and 4 SDs (two of whom showed...

Continue reading

XWELL, Inc. Reports First Quarter 2024 Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) —  XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today reported results for the first quarter ended March 31, 2024. Recent Highlights: XWELL delivered 2024 first quarter revenue growth of approximately 24% from the 2023 first quarter. The Company has reduced its cost structure, simplified its processes, and has maintained continued momentum on its path to profitability. The following demonstrates the positive effects of XWELL’s actions to enhance its business model: Total cost of sales decreased approximately 7% from the 2023 first quarter. General and administrative expenses decreased approximately 47% from the 2023 first quarter. Total operating expenses decreased approximately 26% from the 2023...

Continue reading

Elevai Labs Inc. Reports First Quarter 2024 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

NEWPORT BEACH, Calif., May 15, 2024 (GLOBE NEWSWIRE) — Elevai Labs Inc. (NASDAQ: ELAB) (“Elevai” or the “Company”), a pioneering force in medical aesthetics, today reported financial results for the first quarter ended March 31, 2024. Elevai Labs CEO, Jordan R. Plews, PhD stated, “This quarter, Elevai Labs has demonstrated remarkable year-over-year revenue growth while significantly improving our gross margin, reflecting our commitment to optimizing production and stringent cost management. We remain focused on sustainable growth while enhancing our operational efficiencies and continuing to invest in innovation. These results underscore our adaptability and strategic foresight in meeting market demands.” Financial Results for the Three Months Ended March 31, 2024 Revenue increased to $614,563 for the three months...

Continue reading

Amcomri Provides Further Bi-Weekly Default Status Report

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) — Amcomri Entertainment Inc. (the “Company”) (Cboe CA: AMEN) (Frankfurt: 25YO) (OTC: AMNNF) is providing this further bi-weekly default status report in accordance with its obligations under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”). As previously announced in the Company’s press releases dated April 3, 2024, April 17, 2024 and May 1, 2024, the Company is subject to a management cease trade order (“MCTO”) issued by its principal regulator, the British Columbia Securities Commission (“BCSC”), dated April 3, 2024. The MCTO prohibits the directors and executive officers and other insiders of the Company from trading in or acquiring securities of the Company until two full business days after the Company files with BCSC its consolidated audited annual...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.